SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-005564
Filing Date
2022-02-17
Accepted
2022-02-17 16:10:31
Documents
12
Period of Report
2022-02-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evok-8k_20220217.htm   iXBRL 8-K 37026
  Complete submission text file 0001564590-22-005564.txt   166417

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA evok-20220217.xsd EX-101.SCH 5705
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20220217_lab.xml EX-101.LAB 19431
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20220217_pre.xml EX-101.PRE 11591
6 EXTRACTED XBRL INSTANCE DOCUMENT evok-8k_20220217_htm.xml XML 3551
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 22648155
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences